XNCR Xencor Inc

8-K Current Report

Filed: February 25, 2026

Health Care

Pharmaceutical Preparations

Xencor Inc (XNCR) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q4 and full-year FY2025 results announced Feb 25, 2026 — full figures in Exhibit 99.1
• Period covered: fiscal year ended December 31, 2025

Other Xencor Inc 8-K Filings

8-K Mar 9, 2026

8-K Mar 4, 2026

Get deeper insights on Xencor Inc

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.